Reduced expression of transforming growth factor β type II receptor mRNA in the human adrenocortical carcinoma cell line SW-13

Journal of the Medical Society of Toho University

Volumn 49, Issue 6, 2002, Pages 336-346

  Yamamoto, Natsuko ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Human adrenocortical carcinoma; SW 13; TGF insensitivity; TGF type II receptor; Transforming growth factor

Indexed keywords

GENOMIC DNA; LUCIFERASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CELL LINE; CELL PROLIFERATION; GROWTH INHIBITION; HUMAN; INTRON; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

EID: 0036879781     PISSN: 00408670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Vassilopoulou-Sellin R, Schultz PN: Adrenocortical carcinoma: Clinical outcome at the end of the 20th century. Cancer 92: 1113-1121, 2001
2. Reincke M, Karl M, Travis WH, Mastorakos G, Allolio B, Linehan HM, Chrousos GP: p53 mutations in human adrenocortical neoplasms: Immunohistochemical and molecular studies. J Clin Endocrinol Metab 78: 790-794, 1994
3. Reincke M, Wachenfeld C, Mora P, Thumser A, Jaursch-Hancke C, Abdelhamid S, Chrousos GP, Allolio B: p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan. J Clin Endocrinol Metab 81: 3636-3638, 1996
4. Weber MM, Fottner C, Wolf E: The role of the insulin-like growth factor system in adrenocortical tumorigenesis. Eur J Clin Invest 30(suppl 3):69-75, 2000
5. Gortz B, Roth J, Speel EJ, Krahenmann A, De Krijger RR, Matias-Guiu X, Muletta-Feurer S, Rutmann K, Saremaslani PU, Heitz P, Komminoth P: MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int J Cancer 80: 373-379, 1999
6. Kjellman M, Larsson C, Bäckdahl M: Genetic background of adrenocortical tumor development. World J Surg 25: 948-956, 2001
7. Roberts AB, Sporn MB: Transforming growth factor β. Adv Cancer Res 51:107-145,1988
8. Moses HL, Yang EY, Pietenpol JA: TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 63: 245-247, 1990
9. 1/S-phase growth arrest. Mol Cell Biol 11: 1185-1194, 1991
10. Coffey RJ Jr, Bascom CC, Sipes NJ, Graves-Deal R, Weissman BE, Moses HL: Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor β. Mol Cell Biol 8: 3088-3093, 1988
11. Laiho M, DeCaprio JA, Ludlow JW, Livingstdn DM, Massagué J: Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175-185, 1990
12. Derynck R, Akhurst RJ, Balmain A: TGF-β signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129, 2001
13. Wrana J L, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang X-F, Massaque J: TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014, 1992
14. Derynck R, Feng XH: TGF-β receptor signaling. Biochim Biophys Acta 1333: F105-150, 1997
15. Piek E, Heldin CH, Ten Dijke P: Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J 13: 2105-2124, 1999
16. Massegué J: How cells read TGF-β signals. Nat Rev Mol Cell Biol 1: 169-178, 2000
17. Yang HK, Kang SH, Kim YS, Won K, Bang YJ, Kim SJ: Truncation of the TGF-β type II receptor gene results in insensitivity to TGF-β in human gastric cancer cells. Oncogene 18: 2213-2219, 1999
18. Park K, Kim SJ, Bang YJ, Park JG, Kim NK, Roberts AB, Sporn MB: Genetic changes in the transforming growth factor-β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 91: 8772-8776, 1994
19. Myeroff LL, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, et al.: A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55: 5545-5547, 1995
20. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbauth J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson KV: Inactivation of the TGF-β type II receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1995
21. Tomita S, Deguchi S, Miyaguni T, Muto Y, Tamamoto T, Toda T: Analyses of microsatellite instability and the transforming growth factor-β receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features. Breast Cancer Res Treat 53: 33-39, 1999
22. Vincent F, Hagiwara K, Ke Y, Stoner GD, Demetrick DJ, Bennett WP: Mutation analysis of the transforming growth factor β type II receptor in sporadic human cancers of the pancreas, liver, and breast. Biochem Biophys Res Commun 223: 561-564, 1996
23. Furuta K, Misao S, Takahashi K, Tagaya T, Fukuzawa Y, Ishikawa T, Yoshioka K, Kakumu S: Gene mutation of transforming growth factor β1 type II receptor in hepatocellular carcinoma. Int J Cancer 81: 851-853, 1999
24. Matoba, H, Sugano S, Yamaguchi N, Miyachi Y: Expression of transforming growth factor-β1 and transforming growth factor-β type-II receptor mRNA in papillary thyroid carcinoma. Horm Metab Res 30: 624-628, 1998
25. Bae HW, Geiser AG, Kim DH, Chung MT, Burmester JK, Sporn MB, Roberts AB, Kim SJ: Characterization of the promoter region of the human transforming growth factor-β type II receptor gene. J Biol Chem 270: 29460-29468, 1995
26. Riopel L, Branchaud CL, Goodyer CG, Adkar V, Lefebvre Y: Growth-inhibitory effect of TGF-β on human fetal adrenal cells in primary monolayer culture. J Cell Physiol 140: 233-238, 1989
27. Parker CR Jr, Stankovic AK, Harlin C, Carden L: Adrenocorticotropin interferes with transforming growth factor-β-induced growth inhibition of neocortical cells from the human fetal adrenal gland. J Clin Endocrinol Metab 75: 1519-1521, 1992
28. Lebrethon MC, Jaillard C, Naville D, Begeot M, Saez JM: Effects of transforming growth factor-β1 on human adrenocortical fasciculata-reticularis cell differentiated functions. J Clin Endocrinol Metab 79: 1033-1039, 1994
29. Stankovic AK, Dion LD, Parker CR Jr: Effects of transforming growth factor-β on human fetal adrenal steroid production. Mol Cell Endocrinol 99: 145-151, 1994
30. Feige JJ, Cochet C, Savona C, Shi DL, Keramidas M, Defaye G, Chambaz EM: Transforming growth factor β1: an autocrine regulator of adrenocortical steroidogenesis. Endocr Res 17: 267-279, 1991
31. Boccuzzi A, Terzolo M, Cappia S, De Giuli P, De Risi C, Leonardo E, Bovio S, Borriero M, Paccotti P, Angeli A: Different immunohistochemical patterns of TGF-β1 expression in benign and malignant adrenocortical tumours. Clin Endocrinol (Oxf) 50: 801-808, 1999
32. Garrigue-Antar L, Muñoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF, Reiss M: Missense mutations of the transforming growth factor βtype II receptor in human head and neck squamous carcinoma cells. Cancer Res 55: 3982-3987, 1995
33. Muñoz-Antonia T, Li X, Reiss M, Jackson R, Antonia S: A mutation in the transforming growth factor β type II receptor gene promoter associated with loss of gene expression. Cancer Res 56: 4831-4835, 1996
34. Liu Y, Zhong X, Li W, Brattain MG, Banerji SS: The role of Sp1 in the differential expression of transforming growth factor-β receptor type II in human breast adenocarcinoma MCF-7 cells. J Biol Chem 275: 12231-12236, 2000
35. Choi SG, Yi Y, Kim YS, Kato M, Chang J, Chung HW, Hahm KB, Yang HK, Rhee HH, Bang YJ, Kim SJ: A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-β type II receptor. J Biol Chem 273: 110-117, 1998
36. Hahm KB, Cho K, Lee C, Im YH, Chang J, Choi SG, Sorensen PH, Thiele CJ, Kim SJ: Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet 23: 222-227, 1999
37. Sun L, Wu G, Willson JK, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang XF, Brattain MG: Expression of transforming growth factory β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269: 26449-26455, 1994
38. Chang J, Park K, Bang YJ, Kim WS, Kim D, Kim SJ: Expression of transforming growth factor β type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res 57: 2856-2859, 1997